Real-world persistence of E/C/F/TAF versus DTG+ABC/3TC regimens for treatment of HIV in a large Spanish cohort: VACH

被引：0
|
作者：
Teira, R. [1 ]
Romero, A. [2 ]
Roca, B. [3 ]
Munoz-Sanchez, M. [4 ]
Sepulveda, M. [5 ]
Puig, T. [6 ]
Espinosa, N. [7 ]
Merino, M. [8 ]
Geijo, P. [9 ]
Castano, M. [10 ]
Estrada, V. [11 ]
Ribera, E. [12 ]
Domingo, P. [13 ]
De la Fuente, B. [14 ]
Montero, M. [15 ]
Galindo, M. [16 ]
Peraire, J. [17 ]
Martinez, E. [18 ]
Lozano, F. [19 ]
Terron, A. [20 ]
Garcia, J. [21 ]
Deig, E. [22 ]
Munoz-Sanz, A. [23 ]
Gutierrez, M. [13 ]
机构：
[1] Hosp Sierrallana, Torrelavega, Spain
[2] Hosp Clin, Puerto Real, Spain
[3] Hosp Gen, Castellon de La Plana, Spain
[4] Hosp Basurto, Bilbao, Spain
[5] Hosp Virgen de la Salud, Toledo, Spain
[6] Hosp Arnau Vilanova, Lleida, Spain
[7] Virgen del Rocio, Seville, Spain
[8] Hosp Infanta Elena, Huelva, Spain
[9] Hosp Virgen de la Luz, Cuenca, Spain
[10] Hosp Carlos Haya, Malaga, Spain
[11] Hosp Clin San Carlos, Madrid, Spain
[12] Hosp Valle De Hebron, Barcelona, Spain
[13] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[14] Hosp Cabuenes, Gijon, Spain
[15] Hosp la Fe, Valencia, Spain
[16] Hosp Clin, Valencia, Spain
[17] Hosp Joan 23, Tarragona, Spain
[18] Hosp Albacete, Albacete, Spain
[19] Hosp Valme, Seville, Spain
[20] Hosp SAS, Jerez de la Frontera, Spain
[21] Hosp Santa Lucia, Cartagena, Spain
[22] Hosp Gen, Granollers, Spain
[23] Hosp Infanta Cristina, Badajoz, Spain
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P083
引用
收藏
页数：1
相关论文
共 47 条
  • [1] Adherence to and Forgiveness of 3TC/DTG in a Real-World Cohort
    Maggiolo, Franco
    Valenti, Daniela
    Teocchi, Rodolfo
    Comi, Laura
    Di Filippo, Elisa
    Rizzi, Marco
    [J]. JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2022, 21
  • [2] Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study
    Lagi, Filippo
    Botta, Annarita
    Ciccullo, Arturo
    Picarelli, Chiara
    Fabbiani, Massimiliano
    di Giambenedetto, Simona
    Borghi, Vanni
    Mussini, Cristina
    Bartoloni, Alessandro
    Sterrantino, Gaetana
    [J]. HIV RESEARCH & CLINICAL PRACTICE, 2021, 22 (04) : 96 - 101
  • [3] Early discontinuation of ABC/3TC/DTG and BIC/TAF/FTC single-tablet regimens: a real-life multicentre cohort study
    Lagi, F.
    Botta, A.
    Arturo, C.
    Chiara, P.
    Fabbiani, M.
    Di Giambenedetto, S.
    Borghi, V.
    Mussini, C.
    Bartoloni, A.
    Gaetana, S.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 45 - 46
  • [4] Characteristics and real-world medication persistence of people living with HIV treated with DTG/3TC or BIC/FTC/TAF: a hospital claims database study in Japan
    Kanamori, Rie
    Aoki, Nozomi
    Kanazawa, Akio
    Nakamoto, Daisuke
    Yuda, Mayumi
    Makino, Nao
    Ohata, Emi
    Fukui, Nobuyuki
    Mori, Hirotake
    Yokokawa, Hirohide
    Naito, Toshio
    [J]. FRONTIERS IN MEDICINE, 2024, 11
  • [5] Incidence of metabolic complications among treatment-naive adults living with HIV-1 randomly allocated to B/F/TAF, DTG/ABC/3TC or DTG + F/TAF after 3 years
    Daar, Eric
    Orkin, Chloe
    Sax, Paul
    Koenig, Ellen
    Clarke, Amanda
    Baumgarten, Axel
    Brinson, Cynthia
    Huang, Hailin
    Martin, Hal
    [J]. HIV MEDICINE, 2022, 23 : 12 - 12
  • [6] Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States
    Peng, Siyang
    Tafazzoli, Ali
    Dorman, Emily
    Rosenblatt, Lisa
    Villasis-Keever, Angelina
    Sorensen, Sonja
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 78 - 78
  • [7] B/F/TAF versus ABC/DTG/3TC or DTG + F/TAF in treatment-naive adults with high baseline viral load or low baseline CD4 cell count: week 96 results
    Podzamczer, D.
    Stellbrink, H-J
    Orkin, C.
    Pozniak, A.
    Arribas, J.
    Koenig, E.
    Ramgopal, M.
    Baumgarten, A.
    Wei, X.
    SenGupta, D.
    Martin, H.
    [J]. HIV MEDICINE, 2019, 20 : 18 - 18
  • [8] Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study
    Giacomelli, Andrea
    Conti, Federico
    Pezzati, Laura
    Oreni, Letizia
    Ridolfo, Anna Lisa
    Morena, Valentina
    Bonazzetti, Cecilia
    Pagani, Gabriele
    Formenti, Tiziana
    Galli, Massimo
    Rusconi, Stefano
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [9] Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study
    Andrea Giacomelli
    Federico Conti
    Laura Pezzati
    Letizia Oreni
    Anna Lisa Ridolfo
    Valentina Morena
    Cecilia Bonazzetti
    Gabriele Pagani
    Tiziana Formenti
    Massimo Galli
    Stefano Rusconi
    [J]. BMC Infectious Diseases, 21
  • [10] Safety and efficacy of switching people with HIV to dual treatment with 3TC/DTG and RPV/DTG in real life: results from the SCOLTA cohort
    De Vito, A.
    Ricci, E.
    Orofino, G.
    Taramasso, L.
    Sarchi, E.
    Costa, C.
    Pellicano, G.
    Pagnucco, L.
    Menzaghi, B.
    De Socio, G.
    Celesia, B.
    Piconi, S.
    Maggi, P.
    Bonfanti, P.
    Madeddu, G.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 83 - 85
12345